Indication

Obesity due to leptin receptor (LEPR) deficiency

Obesity due to leptin receptor (LEPR) deficiency is an ultra-rare, monogenic neuroendocrine disorder caused by biallelic loss-of-function variants in the *LEPR* gene. Read more about Obesity due to leptin receptor (LEPR) deficiency

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Obesity due to leptin receptor (LEPR) deficiency therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Obesity due to leptin receptor (LEPR) deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Obesity due to leptin receptor (LEPR) deficiency.

Obesity due to leptin receptor (LEPR) deficiency is an ultra-rare, monogenic neuroendocrine disorder caused by biallelic loss-of-function variants in the *LEPR* gene.

This defect impairs hypothalamic leptin-melanocortin signaling, disrupting satiety perception and energy expenditure.

Clinically, affected individuals present with rapid, early-onset severe obesity driven by persistent hyperphagia that manifests within the first months of life despite normal birth weight.

The condition primarily impacts the neuroendocrine and metabolic systems and is frequently accompanied by endocrine abnormalities, including hypogonadotropic hypogonadism leading to pubertal failure and infertility.

Personalize your experience

Follow Obesity due to leptin receptor (LEPR) deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it